New flu pill shows promise for teens in Late-Stage trial
NCT ID NCT07229820
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This phase 3 trial tests whether the experimental drug ZSP1273 can shorten flu symptoms in teenagers aged 12-17 with uncomplicated influenza A. About 157 participants in China will receive either the drug or a placebo. The main goal is to see how quickly symptoms like cough, fever, and body aches improve.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ZSP1273
What this could lead to
If it works, this could provide a new treatment option to reduce flu symptoms faster in teenagers.
What could go wrong
This is a mid-stage trial with only 157 participants, so results may not confirm effectiveness or safety for wider use. The drug is still experimental.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital
Shanghai, China